{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:11:57Z","timestamp":1788930717717,"version":"build-2803163510"},"reference-count":54,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T00:00:00Z","timestamp":1615593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Technology of the Republic of China","award":["MOST 109-2628-B-038-020"],"award-info":[{"award-number":["MOST 109-2628-B-038-020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Persistent chronic liver diseases increase the scar formation and extracellular matrix accumulation that further progress to liver fibrosis and cirrhosis. Nevertheless, there is no antifibrotic therapy to date. The ketogenic diet is composed of high fat, moderate to low-protein, and very low carbohydrate content. It is mainly used in epilepsy and Alzheimer\u2019s disease. However, the effects of the ketogenic diet on liver fibrosis remains unknown. Through ketogenic diet consumption, \u03b2-hydroxybutyrate (bHB) and acetoacetate (AcAc) are two ketone bodies that are mainly produced in the liver. It is reported that bHB and AcAc treatment decreases cancer cell proliferation and promotes apoptosis. However, the influence of bHB and AcAc in hepatic stellate cell (HSC) activation and liver fibrosis are still unclear. Therefore, this study aimed to investigate the effect of the ketogenic diet and ketone bodies in affecting liver fibrosis progression. Our study revealed that feeding a high-fat ketogenic diet increased cholesterol accumulation in the liver, which further enhanced the carbon tetrachloride (CCl4)- and thioacetamide (TAA)-induced liver fibrosis. In addition, more severe liver inflammation and the loss of hepatic antioxidant and detoxification ability were also found in ketogenic diet-fed fibrotic mouse groups. However, the treatment with ketone bodies (bHB and AcAc) did not suppress transforming growth factor-\u03b2 (TGF-\u03b2)-induced HSC activation, platelet-derived growth factor (PDGF)-BB-triggered proliferation, and the severity of CCl4-induced liver fibrosis in mice. In conclusion, our study demonstrated that feeding a high-fat ketogenic diet may trigger severe steatohepatitis and thereby promote liver fibrosis progression. Since a different ketogenic diet composition may exert different metabolic effects, more evidence is necessary to clarify the effects of a ketogenic diet on disease treatment.<\/jats:p>","DOI":"10.3390\/ijms22062934","type":"journal-article","created":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T22:13:10Z","timestamp":1615759990000},"page":"2934","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Ketogenic Diet Enhances the Cholesterol Accumulation in Liver and Augments the Severity of CCl4 and TAA-Induced Liver Fibrosis in Mice"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9836-1503","authenticated-orcid":false,"given":"Yi-Jen","family":"Liao","sequence":"first","affiliation":[{"name":"School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hsi","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Ying","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Yu","family":"Hsu","sequence":"additional","affiliation":[{"name":"School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ying","family":"Chien","sequence":"additional","affiliation":[{"name":"School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chieh","family":"Lee","sequence":"additional","affiliation":[{"name":"School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"ref_2","first-page":"96","article-title":"Fibrosis\u2014A Common Pathway to Organ Injury and Failure","volume":"373","author":"Rockey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(15)00128-2","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Collaborators","year":"2015","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/cphy.c120035","article-title":"Hepatic stellate cells and liver fibrosis","volume":"3","author":"Puche","year":"2013","journal-title":"Compr. Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1055\/s-2005-858989","article-title":"TGF-beta\/Smad signaling in the injured liver","volume":"44","author":"Breitkopf","year":"2006","journal-title":"Z. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/ejcn.2013.116","article-title":"Beyond weight loss: A review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets","volume":"67","author":"Paoli","year":"2013","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.yebeh.2015.12.008","article-title":"Six-month efficacy of the Ketogenic diet is predicted after 3 months and is unrelated to clinical variables","volume":"55","author":"Wu","year":"2016","journal-title":"Epilepsy Behav."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MCO.0b013e3283547157","article-title":"Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease","volume":"15","author":"Schugar","year":"2012","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Wang, Y.H., Liu, C.L., Chiu, W.C., Twu, Y.C., and Liao, Y.J. (2019). HMGCS2 Mediates Ketone Production and Regulates the Proliferation and Metastasis of Hepatocellular Carcinoma. Cancers, 11.","DOI":"10.3390\/cancers11121876"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Wang, Y.H., Suk, F.M., and Liao, Y.J. (2020). Loss of HMGCS2 Enhances Lipogenesis and Attenuates the Protective Effect of the Ketogenic Diet in Liver Cancer. Cancers, 12.","DOI":"10.3390\/cancers12071797"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neurobiolaging.2016.08.005","article-title":"A ketogenic diet accelerates neurodegeneration in mice with induced mitochondrial DNA toxicity in the forebrain","volume":"48","author":"Lauritzen","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","article-title":"Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics","volume":"25","author":"Puchalska","year":"2017","journal-title":"Cell Metab."},{"key":"ref_16","unstructured":"Dhillon, K.K., and Gupta, S. (2021). Biochemistry, Ketogenesis. StatPearls, StatPearls Publishing."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"983401","DOI":"10.1155\/2014\/983401","article-title":"BHBA suppresses LPS-induced inflammation in BV-2 cells by inhibiting NF-kappaB activation","volume":"2014","author":"Fu","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2049-3002-2-18","article-title":"Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia","volume":"2","author":"Shukla","year":"2014","journal-title":"Cancer Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.3892\/mmr.2017.7641","article-title":"PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review)","volume":"16","author":"Ying","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Twu, Y.C., Lee, T.S., Lin, Y.L., Hsu, S.M., Wang, Y.H., Liao, C.Y., Wang, C.K., Liang, Y.C., and Liao, Y.J. (2016). Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17071122"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.nut.2018.10.003","article-title":"The ketogenic diet as a potential treatment and prevention strategy for Alzheimer\u2019s disease","volume":"60","author":"Broom","year":"2019","journal-title":"Nutrition"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neulet.2009.01.068","article-title":"Ketogenic diet attenuates kainic acid-induced hippocampal cell death by decreasing AMPK\/ACC pathway activity and HSP70","volume":"453","author":"Jeon","year":"2009","journal-title":"Neurosci. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2007.02.009","article-title":"Epidemiology and natural history of NAFLD and NASH","volume":"11","author":"Ong","year":"2007","journal-title":"Clin. Liver Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: The epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/flgastro-2013-100404","article-title":"Non-alcoholic fatty liver disease: A practical approach to treatment","volume":"5","author":"Dyson","year":"2014","journal-title":"Front. Gastroenterol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3945\/ajcn.110.007674","article-title":"Short-term weight loss and hepatic triglyceride reduction: Evidence of a metabolic advantage with dietary carbohydrate restriction","volume":"93","author":"Browning","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.7326\/0003-4819-153-3-201008030-00005","article-title":"Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: A randomized trial","volume":"153","author":"Foster","year":"2010","journal-title":"Ann. Intern Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.nut.2013.11.008","article-title":"Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial","volume":"30","author":"Kani","year":"2014","journal-title":"Nutrition"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jhep.2014.10.024","article-title":"Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine","volume":"62","author":"Healy","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1126\/science.1227166","article-title":"Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Science"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jhep.2018.04.004","article-title":"beta-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway","volume":"69","author":"Chen","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cmet.2018.10.015","article-title":"Hepatocyte-Macrophage Acetoacetate Shuttle Protects against Tissue Fibrosis","volume":"29","author":"Puchalska","year":"2019","journal-title":"Cell Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.tem.2012.05.001","article-title":"PPARs at the crossroads of lipid signaling and inflammation","volume":"23","author":"Wahli","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.nut.2006.08.018","article-title":"Effect of antioxidant capacity on blood lipid metabolism and lipoprotein lipase activity of rats fed a high-fat diet","volume":"22","author":"Yang","year":"2006","journal-title":"Nutrition"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3390\/ijerph110202092","article-title":"Ketogenic diet for obesity: Friend or foe?","volume":"11","author":"Paoli","year":"2014","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1017\/S0007114513000548","article-title":"Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: A meta-analysis of randomised controlled trials","volume":"110","author":"Bueno","year":"2013","journal-title":"Br. J. Nutr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"E552","DOI":"10.1152\/ajpendo.00453.2013","article-title":"Long-term ketogenic diet causes glucose intolerance and reduced beta- and alpha-cell mass but no weight loss in mice","volume":"306","author":"Ellenbroek","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1152\/ajpendo.00478.2010","article-title":"Induction of ketosis in rats fed low-carbohydrate, high-fat diets depends on the relative abundance of dietary fat and protein","volume":"300","author":"Bielohuby","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-7075-9-69","article-title":"Response of C57Bl\/6 mice to a carbohydrate-free diet","volume":"9","author":"Borghjid","year":"2012","journal-title":"Nutr. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molmet.2013.07.003","article-title":"Methionine and choline regulate the metabolic phenotype of a ketogenic diet","volume":"2","author":"Pissios","year":"2013","journal-title":"Mol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"901S","DOI":"10.3945\/ajcn.110.001941","article-title":"Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis","volume":"93","author":"Domouzoglou","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1210\/er.2017-00016","article-title":"Fibroblast Growth Factor 21-Metabolic Role in Mice and Men","volume":"38","author":"Staiger","year":"2017","journal-title":"Endocr. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1530\/EJE-11-0783","article-title":"Decrease in circulating fibroblast growth factor 21 after an oral fat load is related to postprandial triglyceride-rich lipoproteins and liver fat","volume":"166","author":"Matikainen","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1055\/s-0034-1395635","article-title":"Short-term and divergent regulation of FGF-19 and FGF-21 during oral lipid tolerance test but not oral glucose tolerance test","volume":"123","author":"Schmid","year":"2015","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1172\/JCI83349","article-title":"FGF21 and the late adaptive response to starvation in humans","volume":"125","author":"Fazeli","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cmet.2008.06.014","article-title":"The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man","volume":"8","author":"Galman","year":"2008","journal-title":"Cell Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/en.2006-1168","article-title":"The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21","volume":"148","author":"Kharitonenkov","year":"2007","journal-title":"Endocrinology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1210\/jc.2009-0111","article-title":"Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man","volume":"94","author":"Christodoulides","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Ari, C., Murdun, C., Koutnik, A.P., Goldhagen, C.R., Rogers, C., Park, C., Bharwani, S., Diamond, D.M., Kindy, M.S., and D\u2019Agostino, D.P. (2019). Exogenous Ketones Lower Blood Glucose Level in Rested and Exercised Rodent Models. Nutrients, 11.","DOI":"10.3390\/nu11102330"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Harvey, K.L., Holcomb, L.E., and Kolwicz, S.C. (2019). Ketogenic Diets and Exercise Performance. Nutrients, 11.","DOI":"10.3390\/nu11102296"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Monsalves-Alvarez, M., Morales, P.E., Castro-Sepulveda, M., Sepulveda, C., Rodriguez, J.M., Chiong, M., Eisner, V., Lavandero, S., and Troncoso, R. (2020). beta-Hydroxybutyrate Increases Exercise Capacity Associated with Changes in Mitochondrial Function in Skeletal Muscle. Nutrients, 12.","DOI":"10.3390\/nu12071930"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Liao, Y.-J., Wang, Y.-H., Liu, C.-L., Fang, C.-C., Hsu, M.-H., and Suk, F.-M. (2020). 4-methoxy sulfonyl paeonol inhibits hepatic stellate cell activation and liver fibrosis by blocking the TGF-\u03b21\/Smad, PDGF-BB\/MAPK and Akt signaling pathways. Appl. Sci., 10.","DOI":"10.3390\/app10175941"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/6\/2934\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:35:20Z","timestamp":1760160920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/6\/2934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,13]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["ijms22062934"],"URL":"https:\/\/doi.org\/10.3390\/ijms22062934","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,13]]}}}